Genalyte Overview
- Year Founded
-
2007
- Status
-
Private
- Employees
-
96
- Latest Deal Type
-
2ndary - Private
- Investors
-
22
Genalyte General Information
Description
Developer of a diagnostic testing system designed to deliver rapidly deployable mobile laboratories with real-time diagnostics anywhere in the delivery system. The company performs the majority of tests in any healthcare setting with a rapidly deployable mobile laboratory in under thirty minutes, and the central lab handles tests that cannot be performed on-site, enabling physicians to improve the quality of care for patients and reduce resource utilization across the healthcare system.
Contact Information
Website
www.genalyte.comCorporate Office
- 10520 Wateridge Circle
- San Diego, CA 92121
- United States
Corporate Office
- 10520 Wateridge Circle
- San Diego, CA 92121
- United States
Genalyte Timeline
Genalyte Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 11. Secondary Transaction - Private | Completed | Generating Revenue | ||||
| 10. Accelerator/Incubator | 06-Jun-2025 | Completed | Generating Revenue | |||
| 9. Later Stage VC (Series C) | 29-Oct-2024 | Completed | Generating Revenue | |||
| 8. Later Stage VC (Series C2) | 06-Mar-2023 | Completed | Generating Revenue | |||
| 7. Later Stage VC (Series C1) | 11-Jan-2021 | Completed | Generating Revenue | |||
| 6. Later Stage VC | 15-Apr-2020 | Completed | Generating Revenue | |||
| 5. Later Stage VC | 21-Nov-2016 | Completed | Generating Revenue | |||
| 4. Later Stage VC (Series C) | 18-Aug-2015 | Completed | Generating Revenue | |||
| 3. Grant | 18-Oct-2013 | $1M | $15.9M | Completed | Generating Revenue | |
| 2. Later Stage VC (Series B) | 30-Mar-2012 | $11.9M | $15.9M | Completed | Startup |
Genalyte Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series C2 | ||||||||
| Series C1 | ||||||||
| Series C | 166,775,414 | $0.000100 | $0.06 | $1 | $1 | 1x | $1 | 52.42% |
| Series A2 | 1,634,785 | $0.000100 | $0.6 | $10 | $10 | 1x | $10 | 0.51% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Genalyte Comparisons
Industry
Financing
Details
Genalyte Competitors (16)
One of Genalyte’s 16 competitors is SQI Diagnostics, a Corporation company based in Toronto, Canada.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| SQI Diagnostics | Corporation | Toronto, Canada | ||||
| Hain Lifescience | Corporate Backed or Acquired | Nehren, Germany | ||||
| BioGenex Laboratories | Corporation | Fremont, CA | ||||
| PixCell Medical Technologies | Formerly VC-backed | Yokneam Ilit, Israel | ||||
| DiaSys Diagnostic Systems | Corporate Backed or Acquired | Holzheim, Germany |
Genalyte Patents
Genalyte Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4747641-A1 | Automated laboratory system, and cloud laboratory system | Pending | 18-Jul-2023 | ||
| WO-2025019638-A1 | Automated laboratory system, and cloud laboratory system | Inactive | 18-Jul-2023 | ||
| EP-4127714-A1 | Rapid multiplexed serological test | Pending | 02-Apr-2020 | ||
| EP-4127714-A4 | Rapid multiplexed serological test | Pending | 02-Apr-2020 | ||
| US-20210396755-A1 | Rapid multiplexed serological test | Pending | 02-Apr-2020 | G01N33/56983 |
Genalyte Signals
Genalyte Investors (22)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| IPD Capital | Venture Capital | Minority | ||
| MedTech Innovator | Accelerator/Incubator | |||
| Parade Ventures | Venture Capital | Minority | ||
| Seed Healthcare | Venture Capital | Minority | ||
| Boutique Venture Partners | Venture Capital | Minority |
Genalyte Acquisitions (1)
Genalyte’s most recent deal was a Merger/Acquisition with BaseHealth. The deal was made on 12-Mar-2020.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| BaseHealth | 12-Mar-2020 | Merger/Acquisition | Decision/Risk Analysis |
Genalyte FAQs
-
When was Genalyte founded?
Genalyte was founded in 2007.
-
Where is Genalyte headquartered?
Genalyte is headquartered in San Diego, CA.
-
What is the size of Genalyte?
Genalyte has 96 total employees.
-
What industry is Genalyte in?
Genalyte’s primary industry is Diagnostic Equipment.
-
Is Genalyte a private or public company?
Genalyte is a Private company.
-
What is Genalyte’s current revenue?
The current revenue for Genalyte is .
-
How much funding has Genalyte raised over time?
Genalyte has raised $346M.
-
Who are Genalyte’s investors?
IPD Capital, MedTech Innovator, Parade Ventures, Seed Healthcare, and Boutique Venture Partners are 5 of 22 investors who have invested in Genalyte.
-
Who are Genalyte’s competitors?
SQI Diagnostics, Hain Lifescience, BioGenex Laboratories, PixCell Medical Technologies, and DiaSys Diagnostic Systems are some of the 16 competitors of Genalyte.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process